Troy Lister – Bug Battler: Medicinal chemist takes unconventional approach to battling bacteria Posted on July 6, 2015 at 12:52 am.Written by Spero Therapeutics Post navigation Merck & Co. (MRK), New England Patriots Owner Wager $30 Million on Cambridge Startup, SperoSpero Achieves First Milestone Payment in Anti-Infective Partnership with Roche
